No Data
No Data
Hunan Warrant Pharmaceutical Gets Supplementary Drug Approval for Chest Pain Drug
Express News | Warner Pharma Factory: Subsidiary's active pharmaceutical ingredient Salbutamol Sulfate obtains approval notification for market application.
Express News | Warner Pharmaceutical: Received the approval notification for the supplementary application of Benidipine Hydrochloride Tablets.
Hunan Warrant Pharmaceutical Receives 23 Million Yuan in Government Subsidies
Warner Pharmaceutical Factory (688799.SH) received government subsidies of 23.0123 million yuan.
On November 13th, Gelonghui reported that Warner Pharmaceutical Factory (688799.SH) announced that the company, its wholly-owned subsidiaries, and controlling subsidiaries have received a total of RMB 23.0123 million in government subsidies from January 2024 to the date of this announcement, all of which are related to income-related government subsidies.
Express News | Warner Pharmaceutical Factory: Subsidiary passes pharmaceutical GMP compliance inspection
No Data
No Data